The list is arranged by deadline chronological order. Israeli calls first, then foreign calls.
For assistance please contact Research Promotion Unit (RPU): ra-tec@technion.ac.il
Robi
Iris
Luba
-
Normal viewExtended view
-
Filter by:
Israeli
MOST: Applied research 2027 (pre-applications)
משרד המדע והטכנולוגיה: מחקר יישומי 2027 (קדם הצעות)
הגשה לרשות המחקר: 18.11 | הגשה למשרד המדע: 25.11
הקול הקורא ממוקד בתחומים בעלי עדיפות לאומית בתחומים הבאים:
חומרים
חומרים פונקציונליים לסביבות קיצוניות – מחקר יישומי לפיתוח חומרים המסוגלים לשמור על שלמות מבנית ופונקציונליות בתנאי קיצון.
בריאות ורפואה
הזדקנות בריאה ואריכות ימים – פיתוח פתרונות יישומיים וטכנולוגיות חדשניות לקידום הזדקנות בריאה ואריכות חיים.
ביוקונברג’נס
הנדסת מערכות ביולוגיות מתקדמות וביו-חומרים חכמים – פיתוח טכנולוגיות המשלבות עקרונות הנדסיים וביולוגיים לצורך תכנון ובנייה של רכיבים ביולוגיים, מסלולים מטבוליים, אורגניזמים חדשים וביו-חומרים מתקדמים.
הדפסה ביולוגית תלת-ממדית – פיתוח טכנולוגיות הדפסה מתקדמות, תאים וחומרי תמך ביולוגיים (Bio-inks) ליצירת מבנים ביולוגיים מתפקדים עבור יישומים ברפואה, מזון, בנייה, ייצור, חקלאות ועוד.
הנדסה וטכנולוגיות מתקדמות
מערכות הנעה ממוזערות – פיתוח מנגנוני הנעה ומערכות מיקרו-אלקטרו-מכניות (MEMS) ליישומים רפואיים, תעשייתיים וחלליים.
ממשקי מוח-מחשב וסביבות מרחביות – טכנולוגיות מגע ותחושה מתקדמות להגברת תחושת הנוכחות (Embodiment) בסביבות XR, עיצוב מערכות BCI המתאימות את הממשק והעומס הקוגניטיבי על בסיס מעקב עיניים ואינדיקטורים רגשיים.
חלל אזרחי (סוכנות החלל)
ארכיטקטורה, תקשורת ואבטחת מידע למרכזי נתונים בחלל – מחקרים בנושאי פיתוח טכנולוגיות, שיטות ורכיבים לארכיטקטורות מחשוב, אגירה, תקשורת ואבטחת מידע עבור מרכזי נתונים (DataCenters) במסלול בחלל, שיאפשרו העברת תשתיות יבשתיות ללוויינים בעלי עצמאות מבצעית.
סביבה
מינים פולשים בישראל – פיתוח שיטות, טכנולוגיות וגישות חדשניות להתמודדות עם השפעתם של מינים פולשים מזיקים בישראל.
פיזיקה ומדעי המחשב
פוטוניקה משולבת ושבבים אופטיים – תכנון שבבים פוטוניים לעיבוד נתונים במהירות האור.
מדעי החברה
מעורבות אזרחית והגברת אמון – פיתוח מודלים להגברת השתתפות פעילה בקבלת החלטות ברמה המקומית והלאומית.
* בכל תחומי ונושאי קול קורא זה, על המחקרים להיות מקוריים ובעלי התכנות יישומית.
* חוקר רשאי להגיש או להחזיק עד 2 הצעות מחקרים פעילים במסלול הלאומי ללא ההבחנה בין חוקר ראשי למשני (במינוח של משרד המדע: חוקר ראשי – מרכז פרויקט חוקר ראשי(.
תקציב: עד 700 אלף ₪ ל-3 שנים.
קרן המחקרים של משרד המדע: קול קורא להגשת קדם-הצעות מחקר לשנת 2027 משרד החדשנות, המדע והטכנולוגיה
ISF – Workshops
ISF Registration (mandatory): 30.11; ISF submission: 14.12
The program is designated for researchers with an active ISF grant (from the 2nd year until one year after the grant termination) and sponsors research workshops in topics related to the grants. Funding: up to 70K NIS.
BSF Research Grant (Regular Program) – Exact and Physical Sciences, Social Sciences
Submission to Research Authority: by Nov. 11, Final Submission to BSF: by Dec 2.
Israel-U.S. joint research projects addressing topics in basic science.
Funding: up to $300K over 2-4 years for all involved.
https://www.bsf.org.il/funding-opportunities/bsf-research-grants/about/
MIT Global Seed Fund (GSF)
MIT-Middle East Global Collaboration
The Fund is open to MIT faculty to collaborate with a research lab in Israel and from one additional country in the Middle East and North Africa (MENA).
Priority will be given to applications that engage issues across borders and on a regional scale, including Climate & Sustainability (including food and agriculture), Global Health, Artificial Intelligence, and Social Impact.
Maximum Award: $50,000
Funding: up to $50,000.
https://cis.mit.edu/opportunities/seed-funding/available-funds/gsf-middle-east
MIT-Israel Seed Fund: Supporting new research collaborations between MIT and Israel
Funding: up to $30,000.
https://cis.mit.edu/opportunities/seed-funding/available-funds/gsf-israel
Euro-Bioimaging: ISIDORe II for access to RI services on Andes virus and hantavirus research
Offers researchers the opportunity to access, free of charge, specialized expertise, technologies, facilities, and services from across Europe to support research on Andes virus (ANDV) and ANDV-relevant hantaviruses.
Priority will be given to proposals addressing therapeutic and non-vaccine prophylactic candidates; diagnostics, tools, assays, reagents and reference materials; and ANDV models, experimental systems and readouts.
https://isidore-project.eu/calls/andes-virus-andv-relevant-hantavirus-research/
An Information webinar will be held on 28 September 2026 – 2-3:30 PM CEST.
Zoom link: https://us06web.zoom.us/j/81418594472?pwd=3TjaJfSiorM6QQA9eZHvhrrf3S8UwV.1
For registration: https://docs.google.com/forms/d/e/1FAIpQLSev31nmbLo4YRaR0aILb4sGTt-6G6Ch1gKC0-dAf5mKNRMcMQ/viewform
Israel Cancer Research Fund (ICRF) – Funding Opportunities
Project grants: fund projects with clear potential to advance understanding, diagnosis, or treatment of cancer. Support for an established, independent investigators with proven expertise and leadership. While collaboration and interdisciplinary research are encouraged, they are not required. Projects must address human cancer, be backed by solid data, and show potential for meaningful impact within 5–10 years.
Funding: up to 3 years, with a maximum of $60,000 per year
Career Development Awards (CDAs): To enhance the research capabilities of young scientists, with at least 3 years of postdoctoral fellowship and within 5 years of their 1st academic appointment.
Funding: $135K over 3 years.
- The Barbara S. Goodman Endowed Career Development Award (CDA) in Pancreatic Cancer
To apply for this grant, please create a new Career Development Award application in Proposal Central and select “yes” where indicated on the “Project Title” page.
Research Professorships Grants
Aim: to recognize accomplished investigators whose research has significant impact on understanding of cancer. Applicants must hold the rank of Full Professor or equivalent and must have carried out research for at least eight years since receiving the PhD, MD, or MD/PhD degree.
**Applicants to the ICRF Project Grant category ranking in the top 5% of applications may be invited to submit a Vision Statement to be evaluated for consideration of a Research Professorship. In the Vision Statement, applicants will be invited to submit a description of their research objectives for Years 4 and 5 of Research Professorship funding, along with a revised budget to describe the anticipated use of funds totaling up to $100,000 per year over a 5-year period.
Era-Net (MOH)- JTC10: NanoDiagNCD 2027 – ‘Nano and Advanced Technologies for Developing Diagnostic Tools to Improve the Detection and the Clinical Management of Noncommunicable Diseases”
The call will be implemented in two stages, a pre- and a full-proposal phase and will be uploaded on Nov 17.
To support translational research projects that develop application(s) of nanotechnologies, either solely or in combination with Key Enabling Technologies (KETs), to make significant strides in the development of diagnostic and theragnostic tools for Non-Communicable Diseases (NCDs). Proposals should focus on developing and/or validating diagnostic and theragnostic tools that are grounded in robust scientific evidence. The results obtained from these tools must enable the optimization of the care continuum. This care continuum includes, among other things, prevention, early disease detection, disease monitoring, treatment guidance, adverse effect and/or risk/benefit assessment.
Funding: Funding for the Israeli partner: €140,000 over 3 years (additional €40K for Israeli coordination).
* A minimum of three (3) eligible partners asking for funding from three (3) different eligible countries (including at least two amongst EU Member States or Associated Countries).
* A short abstract and budget should be sent to the ministry of Health (MOH) prior to pre-proposal submission.
A webinar will be held on 19 November 2026.
https://era4health.eu/calls/pre_NanoDiagNCD2027.php
Era-Net (MOH): EP PerMed Joint Transnational Call – Cell and Gene Therapy for Personalized Medicine (CGT4PM2027) (Pre announcement)
The call will uploaded on Nov 4.
Will fund research projects in human health on Cell and Gene Therapy (CGT) for PM approaches. Proposals must focus on the development and validation of an innovative and novel CGT for PM.
At least one of the following approaches must be employed:
– Somatic cell therapeutics
– Gene therapeutics
– Combined cell- and gene therapeutics
– Novel biological products such as mRNA, other nucleic acid-based methods, and extracellular vesicles as vehicle for gene-based therapeutic procedure.
Funding: Funding for the Israeli partner: €140,000 over 3 years (additional €40K for Israeli coordination).
* A minimum of three (3) eligible partners asking for funding from three (3) different eligible countries (including at least two amongst EU Member States or Associated Countries).
* A short abstract and budget should be sent to the ministry of Health (MOH) prior to pre-proposal submission.
https://www.eppermed.eu/funding-projects/calls/jtc2027/
Era-Net (MOH): The European Partnership on Transforming Health and Care Systems (THCS) – “Transforming the Health and Care Workforce for Sustainable and Resilient Systems”
The call will be implemented in two stages, a pre- and a full-proposal phase and will be uploaded on Nov 16.
Aims to support implementation-oriented research and innovation that accelerates the uptake, adaptation, testing, evaluation and scaling of evidence-informed approaches to health and care workforce transformation. Building on existing knowledge and
previously developed tools, frameworks and good practices, the call seeks to support health and education authorities, health and care providers, educational institutions and other relevant stakeholders in applying and sustaining effective workforce solutions in their specific contexts.
Funding: Funding for the Israeli partner: €140,000 over 3 years (additional €40K for Israeli coordination).
* A minimum of three (3) eligible partners asking for funding from three (3) different eligible countries (including at least two amongst EU Member States or Associated Countries).
* A short abstract and budget should be sent to the ministry of Health (MOH) prior to pre-proposal submission.
A webinar will be held on 2 December 2026 14:30-16:30 CET.
https://www.thcspartnership.eu/funding/jtc-2027-pre-announcement.kl
Era-Net (MOH): One Health AMR (EUP-OH-AMR) – Understand Model and Stop AMR Transmission (Pre announcement)
The call will be implemented in two stages, a pre- and a full-proposal phase and will be uploaded on Nov 18.
The call will focus on preventing the emergence and spread of antimicrobial resistance (AMR), one of the most pressing global health challenges affecting humans, animals and the environment.
Topic 1: Model AMR transmission dynamics to predict the risk of AMR emergence and spread to support decision-making of public authorities.
Topic 2: Understand and characterize the role of host commensal micro-organisms (including fungi) in AMR dynamics and develop solutions aiming at selective decolonizing of resistant organisms in the host (human and animals) to prevent transmission.
Topic 3: Develop or improve tools and methods to reduce resistant bacteria, fungi, and resistance genes in environmental hotspots, and investigate the impact of these tools and methods on AMR transmission.
Funding: €140K over 3 years (additional €40K for Israeli coordination)
* A minimum of three (3) eligible partners asking for funding from three (3) different eligible countries (including at least two amongst EU Member States or Associated Countries).
* A short abstract and budget should be sent to the ministry of Health (MOH) prior to pre-proposal submission.
https://ohamr.eu/2026/10/19/pre-announcment-call-to-advance-research-on-amr-transmission/
NSF-BSF programs
Israeli researchers can join research proposals submitted by US PI(s) to the NSF, in the programs listed below. Two applications per calendar year (Oct 1 – Sept 30) are permitted.
The Israeli budget is funded by the BSF as follows: up to $114K/yr for experimental studies and $94K/yr for theoretical and computer-based studies.
* If more than one lab will be involved in the research they will able to request up to 150% of the budget. These sums are subject to the availability of funds.
Pay attention to the application deadlines. While many programs are open all year long, some still have specific time limits.
Details on all NSF-BSF programs: www.bsf.org.il/funding-opportunities/nsf-bsf-joint-research-grants/the-programs/
Biological Sciences – BIO Core (NSF 26-517)
The former core solicitations of the Divisions of Environmental Biology (DEB), Integrative Organismal Systems (IOS), and Molecular and Cellular Biosciences (MCB) have been replaced by a single Core Research in Biological Sciences (BIO Core) solicitation.
Researchers who previously submitted to DEB, IOS, or MCB should now submit through BIO Core. Proposals are centrally assigned by NSF to the appropriate review unit.
Proposals are accepted anytime.
Mathematical Sciences – MPS MathSci (NSF 26-520)
The new Mathematical Sciences solicitation consolidates NSF’s core mathematics programs, including Algebra and Number Theory, Analysis, Applied Mathematics, Combinatorics, Computational Mathematics, Foundations, Geometric Analysis, Mathematical Biology, Probability, Statistics, and Topology.
Proposals are accepted anytime. Target submission dates vary by program.
Researchers should check the relevant individual NSF program webpage for the applicable target date.
Physics – MPS Physics (NSF 26-523)
The new MPS Physics solicitation consolidates NSF’s core physics research programs.
Proposals are accepted anytime. Target submission dates vary by program.
Researchers should check the relevant individual NSF program webpage for the applicable target date.
Astronomical Sciences – MPS Astro (NSF 26-522)
Astronomical Sciences is now covered by a new solicitation.
Proposals are accepted anytime. Next target submission date: November 16, 2026.
Proposals received after the target date may be reviewed in the following fiscal year.
Chemistry – MPS Chemistry Research Programs (NSF 26-519)
The new Chemistry solicitation consolidates nine disciplinary chemistry research programs.
Proposals are accepted anytime beginning September 1, 2026.
Geosciences – GEO Core (NSF 26-516)
The new Geosciences Core Research solicitation consolidates core research opportunities across Atmospheric and Geospace Sciences, Earth Sciences, and Ocean Sciences.
This includes research areas such as Biological, Chemical, and Physical Oceanography; Marine Geology and Geophysics; Earth Sciences; and Atmospheric and Geospace Sciences.
Proposals are accepted anytime.
BSF Call for Proposals
Engineering
NSF has also introduced new consolidated solicitations for several Engineering divisions:
Electrical, Communications and Computing Systems (ECCS) – NSF 26-514
Proposals are accepted anytime.
Civil, Mechanical and Manufacturing Innovation (CMMI) – NSF 26-515
Proposals are accepted anytime.
Chemical, Bioengineering, Energy and Transport Systems (CBET) – NSF 26-518
Proposals are accepted anytime.
EFRI – Wave-Based Computing (EFRI-WBC) (NSF 26-524)
NSF has announced a new Emerging Frontiers in Research and Innovation: Wave-Based Computing (EFRI-WBC) funding opportunity.
A two-page Concept Outline is required by November 19, 2026 for the FY 2027 competition. Only investigators invited by NSF following review of the Concept Outline may submit a full proposal.
Concept Outline deadline: November 19, 2026
Full proposal deadline: February 11, 2027
CISE – Future Computing Research (Future CoRe)
The new Future Computing Research (Future CoRe) solicitation consolidates several foundational CISE research programs, including areas previously covered under Computing and Communication Foundations (CCF), Computer and Network Systems (CNS), Information and Intelligent Systems (IIS), and Cyber-Physical Systems.
Proposals are accepted anytime.
Upcoming target submission dates:
- September 10, 2026
- February 4, 2027
Upcoming Dates at a Glance
September 1, 2026 – MPS Chemistry begins accepting proposals anytime
September 10, 2026 – CISE Future CoRe target submission date
November 16, 2026 – MPS Astronomical Sciences target submission date
November 19, 2026 – EFRI-WBC Concept Outline deadline
February 4, 2027 – CISE Future CoRe target submission date
February 11, 2027 – EFRI-WBC full proposal deadline
ICL (Israeli Chemicals Ltd): ICL Open Innovation (Crop Nutrition and Applied Agronomy)
ICL is looking to fund research projects in the following domains:
Crop Nutrition:
- Enhanced Efficiency Fertilizers
- Biostimulants
- Biodegradable CRF Coating
- Nitrogen Fixation
- Organic Fertilizers
- Secondary nutrients
- Delivery Platform
- Ammonia synthesis
- Increased P-availability
Applied Agronomy
- Efficient fertilizers application
- Regenerative Agriculture practical methods
- Water use efficiency practical methods
- Nutrient balance (plant, soil, water, atmosphere) sensing/analysis
- GHG emissions sensing/analysis
- Soil microbiome sensing/analysis
- Soil/groundwater contamination sensing/analysis
- Yield estimation by remote sensing
- Plant nutrition’s DSS
Funding: The budget for the selected proposals will be negotiated with ICL
For further details, please contact Adi Perelman Adi.Perelman@icl-group.com
Israel Research Core Facilities: Database of International Scientific Events & Opportunities
Israel’s membership in several leading international research organizations provides access to a diverse range of activities, including workshops, training programs, facility visits, open calls, and occasional funding schemes. These opportunities are not research grants, but rather support professional development, technical training, scientific networking, and, in some cases, industry-focused collaboration.
Since the offerings vary widely in scope and purpose, researchers are encouraged to consult the Events and Opportunities page, which is updated regularly and includes conferences, webinars, hands-on courses, fellowships, training programs, and other activities provided by major European research infrastructures.
Researchers who identify a relevant opportunity are invited to review the details directly and proceed according to the specific guidelines of the hosting organization.
https://www.israel-cores.org/Unlocking-new-opportunities-for-our-scientists-on-the-global-stage
Foreign
Cancer Research Institute (CRI): Technology Impact Award – LOI
Designed to support early-stage, pre-development concepts — innovations that have not yet been built or tested, but that hold the potential to transform the landscape of cancer immunotherapy.
The most competitive applicants will propose innovations that address areas where technological advancement can have the greatest impact on cancer immunotherapy and patient outcomes. Such technologies may include, but are not limited to:
Computational systems biology approaches, Advanced cancer (or molecular) profiling technologies, Real-time visualization technologies, Complex multicellular culture systems and Novel therapeutic technologies.
Funding: seed funding of up to $600K over 2-4 years (10% overhead in addition to awarded funds)
https://www.cancerresearch.org/technology-impact-award
DKMS Stiftung Leben Spenden: Young researcher Research Grant in blood cancer and allogeneic hematopoietic stem cell transplantation
Provides support to promising young researchers to advance the understanding of complications and therapeutic strategies in the context of hematological diseases.
Applicants must have received a doctoral degree (PhD, MD, or equivalent achievements) in a field pertinent to the grant within the last 10 years from the grant call start date.
Applicants from all countries are welcome to apply.
Funding: € 240,000 for a time period of three years.
https://professional.dkms.org/research-publications/research-grant
National Ataxia Foundation (NAF): Research Grants – Letters of intent
NAF funds research through 7 distinct award mechanisms:
-Early Career Investigator Award: a $50,000. 1-year, merit-based, nonrenewable grant designed to support outstanding early-stage scientists who have completed their postdoctoral training within the past 6 years and hold a junior faculty or clinical fellow appointment. This award aims to foster the development of independent research careers by providing seed funding for innovative, high-impact studies in the field of ataxia. Proposals are welcome across the full spectrum of basic, translational, and clinical research, but must have a clear and significant focus on advancing our understanding of the causes, pathogenesis, or treatment of hereditary, sporadic, or acquired ataxias.
-Research Seed Money Award: provides support for new and innovative studies that advance understanding of the cause, pathogenesis, or treatment of hereditary, sporadic, and acquired ataxias. These $50,000, 1-year, merit-based, nonrenewable grants serve as seed funding to assist investigators during the early or pilot phases of research, or as supplemental funding for ongoing innovative projects demonstrating a critical need. It is expected that funded projects will generate preliminary data to support applications for larger grants from other funding sources.
-Pioneer SCA3 Translational Award: s annually granted to independent researchers to support outstanding research proposals that aim to make significant advancements in the development of treatments and/or improvements to patient care for Spinocerebellar Ataxia Type 3 (SCA3). This 1-year, merit-based, nonrenewable grant provides $100,000 in direct research funding. Proposals must have a predominant focus on SCA3 preclinical, translational, or clinical research.
-Michael Lundquist Grant to Advance MSA-C Research: a $50,000, 1-year, merit-based, nonrenewable grant awarded annually to independent researchers for outstanding proposals that aim to make meaningful advancements in the treatment and care of individuals affected by multiple system atrophy, cerebellar subtype (MSA-C). While proposals may include aspects relevant to other forms of ataxia, the primary focus must be on preclinical, translational, or clinical research directly related to MSA-C.
American Association for Cancer Research (AACR): The Bosarge Family Foundation-Waun Ki Hong Scholar Award for Regenerative Cancer Medicine
To encourage and support postdoctoral or clinical research fellows to conduct highly novel and provocative research in the field of regenerative cancer medicine and to establish a successful career path in this field. The research proposed for funding may be translational, clinical, or population sciences in nature and must have direct applicability and relevance to enhancing the physiology of cancer survivors (and/or mitigating the negative effects of their cancer treatment) using regenerative medicine approaches.
Funding: $120K for 2 years
https://www.aacr.org/grants/the-bosarge-family-foundation-waun-ki-hong-scholar-award-for-regenerative-cancer-medicine/
UK Research and Innovation (Medical Research council): UK Obesity Research Institute
Funding to establish the UK Obesity Research Institute, a major multidisciplinary research initiative focused on understanding the biological mechanisms underlying obesity and developing new approaches for the prevention and treatment of obesity and its complications. This is a large-scale, institute-building opportunity, rather than a standard individual research grant. Researchers interested in participating should ideally establish contact with a relevant UK-based research group/consortium early in the process.
The application must be led by a UK research organisation eligible for MRC funding.
International researchers/institutions may potentially participate as collaborators, subject to UKRI/MRC eligibility and funding rules.
Funding available is up to £72 million for an initial seven years, with the potential to renew.
https://www.ukri.org/opportunity/uk-obesity-research-institute/
Nature Awards: MDx Impact Grants
Focus on Alzheimer’s disease (AD), inviting researchers to propose how Seegene’s high-multiplex PCR platform could be applied to the detection and characterization of molecular markers associated with neurodegenerative disease, with a specific focus on Alzheimer’s disease and, where feasible, disease staging and progression assessment.
Funding: $600K
https://www.nature.com/immersive/mdximpactgrants/for-applicants/index.html
https://www.nature.com/immersive/mdximpactgrants/index.html
American Association for Cancer Research (AACR): Lustgarten Foundation Career Development Award for Pancreatic Cancer Research, in Honor of John Robert Lewis
The intent of this program is to support the development and diversity of promising talent working in pancreatic cancer research, particularly investigators from historically underrepresented groups. Selection is competitive and will be based on outstanding accomplishments in scientific research, quality of the research proposal, and fit with the goals and mission of the Lustgarten Foundation.
Funding: $300K for 3 years
https://www.aacr.org/grants/aacr-lustgarten-foundation-career-development-award-for-pancreatic-cancer-research-in-honor-of-john-robert-lewis/
American Association for Cancer Research (AACR): Lustgarten Foundation Career Development Award for Pancreatic Cancer Research, in honor of Ruth Bader Ginsburg
The intent of this program is to support the development and diversity of promising talent working in pancreatic cancer research, particularly female investigators. Selection is competitive and will be based on outstanding accomplishments in scientific research, quality of the research proposal, and fit with the goals and mission of the Lustgarten Foundation.
Funding: $300K for 3 years
https://www.aacr.org/grants/aacr-lustgarten-foundation-career-development-award-for-pancreatic-cancer-research-in-honor-of-ruth-bader-ginsburg/
The Brain Tumour Charity: Translational Award
The Translational Award provides funding to help promising brain tumour innovations move closer to clinical evaluation. The scheme aims to fund the focussed validation of projects that have progressed beyond discovery research and are ready to address a clearly defined translational evidence gap.
Applications are welcomed for any modality with a clear potential to benefit people with a primary brain tumour, including Therapeutics, Diagnostics, Drug-delivery technologies, Medical Devices, Surgical or imaging technologies and Software-enabled clinical technologies.
The award is not intended to support discovery science, exploratory target or biomarker identification, open-ended platform development or mechanistic studies without a defined translational decision.
The award is open to international researchers.
.Application: Two-stage process, all applications should be made through the grant management portal
.Funding: Up to £400,000 for a maximum of 18 months
Bavarian Research Alliance: Funding Programme for the Initiation of International Research Collaborations in Bavaria
Supports Bavarian state and church-affiliated universities as well as universities of applied sciences (UAS) in establishing international research collaborations and preparing joint research funding proposals.
The funding enables researchers to build new international partnerships and prepare joint third-party funding proposals. Funding is exclusively provided for meetings between Bavarian researchers and their specific partner institutions that serve the targeted initiation or deepening of joint cooperation. The programme therefore focuses on institutionally anchored research partnerships.
Funding: up to EUR 10,000 per project
https://www.bayfor.org/en/about-us/mission/initial-funding-programme-bayintan.html
Biocodex Microbiota Foundation: Diet-Microbiome Interactions Shaping Immune Function in the Treatment of Human Disease
Research projects focused on human gut microbiota related to health and disease. Either clinical or fundamental research proposals can be submitted.
The project should involve Microbiome analysis, Immunophenotyping and a dietary component. The project should be primarily performed in humans and in a disease context (Studies purely on healthy subjects are excluded). Pure observational studies should be avoided and some experimental validation is expected.
Funding: up to €200,000 over 3 years.
www.biocodexmicrobiotafoundation.com/international-research-grant/international-call-projects
Environmental Research & Education Foundation (EREF)
Submitted pre-proposals must relate to sustainable solid waste management practices and at least one of the following Priority areas:
- Climate Change Impacts/Greenhouse Gas Emissions
- Emerging Contaminants
- Advancing Materials Circularity & Recycling.
Funding: from $15K to over $500K (average $160K) for typically 2 years.
* It should be noted that proposed research, more than $300,000 or longer than 3 years should contain sufficient details that justify the need for the higher-than-average amount requested and longer project duration.
Association for the Advancement of Blood & Biotherapies (AABB)
Process Development Grant: provides up to $100K to support innovative processes, technologies, tools, and operational models that advance the safe, available, and effective delivery of transfusion medicine and biotherapies. The grant is intended to help improve operational performance, efficiency, quality, safety, accessibility, or decision support.
https://www.aabb.org/foundation/process-development-grant
Early-Career Scientific Research Grant: provides up to $100K to support investigator-initiated, original research in blood banking, transfusion medicine, and biotherapies. The grant is intended to help early-career investigators advance toward research independence through one- or two-year projects.
An early-career investigators is one that has completed a terminal research degree or medical residency – whichever date is later – within the past 10 years of the grant application deadline and has not yet been awarded a substantial research grant (i.e. NIH R01).
https://www.aabb.org/foundation/early-career-scientific-research-grants-program
American Association for Cancer Research (AACR): Kids Beating Cancer Margaret Guedes Monosomy 7 Legacy Cancer Research Grant
This grant seeks to support innovative research aimed at advancing biological understanding, identifying therapeutic vulnerabilities, improving response assessment, addressing relapse, and enhancing survivorship—especially in monosomy 7 and related high-risk cytogenetic subtypes. The program aims to accelerate progress toward improved outcomes for patients with high-risk AML subtypes for which effective treatment options and long-term outcomes remain limited.
Funding: $300K for 3 years
https://www.aacr.org/grants/aacr-kids-beating-cancer-margaret-guedes-monosomy-7-legacy-cancer-research-grant/
Advanced Research + Invention Agency (ARIA): Robot Dexterity
Seeking proposals that address a clearly defined barrier affecting multiple developers or users of dexterous robotic systems. Proposals may focus on one area or combine several. Successful projects will define the problem with the developers and users affected by it, deliver practical, reusable outputs with measurable success criteria, validate their work across independently developed technologies and test sites, and demonstrate a credible route to international adoption, engaging established standards bodies where appropriate. A standalone product or research advance with no credible wider use would not meet the purpose of this call.
Funding: up to £3M for 24 months per consortia
https://aria.org.uk/opportunity-spaces/adaptive-machines/robot-dexterity/funding
Cancer Research UK: Early Detection and Diagnosis Project Award
This award funds exceptional science to drive transformational change in how and when early cancers and pre-cancerous states are detected and diagnosed.
Eligibility: The PI has to be a scientist, clinician or healthcare worker based in a UK university, medical school, hospital or research institution. Supporting roles from international and commercial organisations may also be included as co-investigators and collaborators.
Funding: Up to £500k over 4 years.
Oxalosis & Hyperoxaluria Foundation: Research Grant
The OHF seeks to support research that will ultimately lead to new diagnostics, treatments, and a cure for primary hyperoxaluria and related hyperoxaluria conditions.
Funding: up to $200,000 over two years.
Open AI: Cybersecurity Grant Program application
Looking for thoughtful, focused ideas at the intersection of AI and security.
https://openai.com/form/cybersecurity-grant-program/
Lennox-Gastaut Syndrome (LGS) Foundation: Research Grants (LOI)
We support innovative basic, translational, and clinical research that advances understanding and care for LGS.
Priority Research Areas: LGS biomarkers that predict disease course and/or treatment response / Mortality in LGS / Medical device use in LGS / Disease-modifying therapies targeted to the LGS Secondary Brain Network / Natural history of LGS / Non-seizure issues & quality of life in LGS / Prevention, reversal, and/or stabilization of LGS / Neurodegeneration in LGS / Pediatric-to-adult transition of care in LGS
Funding: up to $75K over 1–2 years.
www.lgsfoundation.org/365-research-grant
www.lgsfoundation.org/wp-content/uploads/2025/11/RFP_-LOI-and-Full-Proposal-Instructions-.docx.pdf
Stanford Center for Ocean Solutions: Blue Food Futures Research Grant Program
A six-month research grant to a researcher in blue food research and stakeholder engagement, particularly with civil society, the private sector, and governments, to inform policy. This grant program is particularly suited to early-career scholars with a strong interest in climate change and biodiversity implications, sustainable, equitable, and resilient blue food transitions, and blue food trade.
Funding: $10K over 6 months.
https://oceansolutions.stanford.edu/sites/g/files/sbiybj25061/files/media/file/blue-food-futures-research-grant-program-announcement_october-2025.pdf
International Center for Responsible Gaming (ICRG): travel grant for researchers
Ongoing in 2026
To support the participation of early-career investigators at scientific meetings at which they are scheduled to present a paper or a poster on gambling disorder research.
* Travel Grants are available to scientists who are not more than 10 years beyond their MD, PhD or other terminal degree.
Funding: up to $1,500
https://www.icrg.org/research/resources/
https://www.icrg.org/information/apply-for-icrg-funding/
DIV Fund: Innovations Tackling Global Poverty
Supports solutions with the potential to cost-effectively improve the lives of millions of people living in poverty around the world. We aim to serve as a discovery engine for global development, building a pipeline of evidence-driven innovations that drive impact at scale.
The DIV Fund supports innovators and researchers piloting, rigorously testing, and scaling ways to meaningfully and measurably improve the lives of people living in poverty. We are deliberately open to all kinds of innovations, operating across all sectors, with potential to impact the lives of millions of people when delivered at scale.
The proposed work must focus on addressing challenges in eligible low- and middle-income countries in line with the World Bank’s income classifications.
Funding: Stage 1 grants of up to $200,000 total; Stage 2 grants of up to $500,000; and Stage 3 grants of up to $1.5 million.
These are ceilings – actual amounts depend on the scope and needs of each proposal.
www.div.fund/apply/rfp
www.div.fund/apply
Jeffrey Modell Foundation for research in Primary Immunodeficiencies
Specific Defect Research Program
Funding collaborative research that explores individual immune system defects and their clinical impact.
Funding: up to $50K over two years.
C.H.I.L.D.R.E.N Global Research Program
Supports research focused on improving outcomes for children with PI worldwide—advancing diagnostics, treatment, and healthcare equity, especially in developing countries.
Funding: up to $50K over two years.
G.E.N.I.E. Program
Advance physician education, foster global collaboration, and promote early diagnosis and better care for Primary Immunodeficiency patients worldwide.
Funding: up to $10K for one year
www.info4pi.org/medical/grants
Renaissance Foundation: AI For Math Fund Seed Grants
Accepted on a rolling basis
A grant program for projects applying artificial intelligence and machine learning methods to advance mathematical research.
Smaller, faster-moving awards designed to de-risk early-stage ideas, validate prototypes, and support emerging opportunities that could lead to larger follow-on projects.
Funding: $100K for 12 months
https://www.renaissancephilanthropy.org/ai-for-math-fund
https://docs.google.com/document/d/1WOTctEoNMOypKb3XB01pldDPHo2wN2ZFhZhjkXwOCc0/edit?tab=t.0
U.S. Army Corps of Engineers: Engineer Research and Development Center (ERDC) BAA – Pre-proposals
Pre-proposals accepted at any time until deadline
various research and development topic areas: hydraulics, dredging, coastal engineering, instrumentation, oceanography, remote sensing, geotechnical engineering, earthquake engineering, soil effects, vehicle mobility, self-contained munitions, military engineering, geophysics, pavements, protective structures, aquatic plants, water quality, dredged material, treatment of hazardous waste, wetlands, physical/mechanical/chemical properties of snow and other frozen precipitation, infrastructure and environmental issues for installations, computer science, telecommunications management, energy, facilities maintenance, materials and structures, engineering processes, environmental processes, land and heritage conservation, and ecological processes.
https://www.erdcwerx.org/wp-content/uploads/2026/01/W912HZ26S0001-January-2026-FINAL.pdf
https://simpler.grants.gov/opportunity/98696099-8a71-4a7c-8e2d-1dfcf3817f75
The Lustgarten Foundation: Innovation & Collaboration Program
To provide seed funding for highly innovative research with significant potential to accelerate the mission of the Lustgarten Foundation. Proposals should address key outstanding questions and have the potential to lead to a change in the current paradigm or conventional wisdom. Proposals that involve collaborations across groups or that bring new expertise and/or technology into the field will be preferred.
Funding: up to $110 for 1 year
https://lustgarten.org/innovation-collaboration-rfa/
NephCure – Pilot Grant Program in glomerular disease – LOI
Supports studies that employ CureGN and or NEPTUNE resources to advance clinical and translational research in glomerular disease. Projects can include, but are not limited to, those that can be used to generate feasibility data to support advancement of promising future studies and projects to develop clinical assays, or protocols, or early phase clinical trials.
Funding: up to $250,000 per project in direct costs only, paid over a 2-year period
Huntington’s Disease Foundation (HDF) (formerly Hereditary Disease Foundation): Transformative Research Award – competitive LOI
To advance transformational collaborative projects to provide new insights into disease mechanisms or create or implement tools and technologies not previously applied to Huntington’s disease research for the advancement of therapeutics. General areas include but are not limited to: whether modulation of somatic repeat instability is disease modifying, whether and how cellular, biochemical or molecular insights in HD systems are predictive of disease, or how to apply unexplored therapeutics for clinical application (inclusive of biomarkers). Projects that discover disease modifying targets and incorporate novel tools or technologies are encouraged. Projects must justify how results could ultimately connect to therapies.
Funding: $300K-$500K per year for up to a two-year period.
Biocodex Microbiota Foundation: Microbiota & Women’s Health – Unraveling male-female genital microbiome interactions: mechanisms, transmission, and impact on vaginal dysbiosis
Research proposals involving the microbiota and its implication in Women’s Health and Disease. Either clinical or fundamental research proposals can be submitted.
Proposals could include, but are not limited to, mechanistic studies elucidating how the penile microbiome contributes to the establishment, persistence, and recurrence of vaginal dysbiosis, including bacterial vaginosis. Areas of interest include microbial transmission dynamics during sexual activity, niche adaptation and persistence of BV-associated taxa in the penile environment, and the functional consequences of these interactions for vaginal community stability. Studies evaluating how current and emerging interventions, such as antibiotics, topical or systemic partner therapies, circumcision, or live biotherapeutic products, alter penile microbial ecology and, in turn, influence treatment response and recurrence risk in female partners are also encouraged.
STI-related projects, except bacterial vaginosis, are not eligible. Clinical studies may be submitted only after approval by an accredited ethics committee.
Funding: up to €200,000 over 3 years.
Department of Health and Human Services (HHS)\ Autism – Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA) – Solution Summary
ARPA-H announced the launch of the new Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA) program, a major research effort to transform how autism is understood, diagnosed, and supported across the lifespan. SPECTRA will bring together biological, clinical, behavioral, and real-world data with advanced computational tools to enable earlier and more accurate diagnosis, identify factors that shape individual health and developmental trajectories, and develop more precise approaches to care tailored to each person’s needs.
To achieve the goals of this program, ARPA-H seeks bold, cross-disciplinary solutions across four technical areas (TAs):
- TA 1 – Analysis: Tools to characterize the genetic, environmental, family, metabolic, immune, and developmental factors associated with distinct developmental, health, communication, and functional trajectories
- TA 2 – Modeling: Federated, privacy-preserving AI platforms that map these trajectories and identify modifiable outcome drivers and actionable targets
- TA 3 – Precision Intervention: Individualized selection and rigorous testing of interventions to improve outcomes across the lifespan.
- TA 4 – Enabling Technologies: Accessible tools for communication, quality of life, and embedded assessment that measure real-world function as a byproduct of ordinary use. To learn more, download the TA4 Overview Briefing (pdf 3MB).
Rosetrees: Major Project grants – Preliminary Applications
Support innovative research projects with an established proof-of-concept. It is expected that funding will enable projects to develop further towards clinical translation and should target an unmet clinical need impacting a significant patient population in the UK. Proposals focusing on rare diseases will also be considered if applicants can demonstrate that their research has potential applications to a broader range of clinical conditions.
Funding: up to £210,000 over 3 years, capped at £70,000 per year (No overhead).
* application must include an element of matched funding alongside the amount requested from Rosetrees to cover directly incurred costs. This matched funding can come from secured grants or in-kind support.
https://rosetrees.org.uk/project_awards/
Cancer Research UK: Early Detection and Diagnosis Programme Award
This award funds long-term, integrated and potentially renewable programmes of exceptional science to drive forward a transformational change in how early cancers and pre-cancerous states are detected.
Eligibility: The PI has to be a scientist, clinician or healthcare worker based in a UK university, medical school, hospital or research institution. Supporting roles from international and commercial organisations may also be included as co-investigators and collaborators.
Funding: Up to £2.5m over 5 years.
The Lustgarten Foundation: Equity, Accessibility, and Diversity (LEAD) Project
Will support projects that propose to make intentional efforts to address barriers to participation among underrepresented groups and develop and implement specific tools to increase clinical trial participation. Applications should have specific, achievable, and measurable goals for increasing the recruitment and retention of patients from underrepresented minority groups in pancreatic cancer clinical trials.
Funding: up to $150 for 3 years
https://lustgarten.org/lead-rfa/
Rosetrees: NEXT Award – Preliminary Applications
RA mandatory submission (to: ra-tec@trdf.technion.ac.il): 1.3.27 (1 page); Final submission by 8.6
Rosetrees is seeking an exceptional researcher ready to deliver major, patient focused impact. As a unique private charity funding pioneering medical research, we back bold thinkers with high risk, high reward ideas. The NEXT Award is the most ambitious initiative yet – designed to propel one outstanding researcher toward a breakthrough in their chosen disease area.
Welcome high potential technologies across: Therapeutics, Devices, Diagnostics, Digital health, Cell and regenerative medicine.
Funding: £150k per year for years 1-3 (total £450k), with a formal Year 3 review with potential for 2 years additional funding for up to £300k (£150k per year, (No overhead)
Please note: Each institute can submit on proposal. The office of the Executive Vice President for Research (MANLAM) will conduct an internal review to determine the one, therefore we request one page abstract by 1.3.
https://rosetrees.org.uk/next/
Rosetrees: Seedcorn grants
Help researchers to generate high-quality preliminary data to advance innovative and novel ideas with the potential to transform the prevention, diagnosis and/or treatment of human diseases. For impactful, ‘out-of-the-box’ ideas.
Applicants should have a novel and innovative hypothesis and some preliminary data that can be developed further. We prioritize exciting ideas with the greatest potential to secure further funding and grants. We will consider both pre-clinical and clinical research studies.
Priority areas: Sepsis Research, Human-specific research.
*For first-time or more junior principal applicants it is recommended that a more experience co-applicant is included as part of the team.
Funding: £20K funding over 12 months for preclinical studies and over 18 months for clinical studies (No overhead).
https://rosetrees.org.uk/seedcorn-awards/
DARPA\Tactical Technology Office (TTO: TTO Office-Wide (OW) Solicitation (Abstracts)
Topics of Interest
TTO seeks to create decisive advantages across all warfighting domains. The portfolio includes, but is not constrained to, new naval and aerospace platforms, novel propulsion technologies, advanced autonomy, and advanced munitions, all designed to maximize impact on current and future battlefields.
To avoid submissions that duplicate existing activities or are responsive to other published TTO
solicitations, potential proposers are highly encouraged to review current TTO programs and
solicitations, respectively listed at https://www.darpa.mil/about/offices/tto
and https://www.darpa.mil/about/offices/tto#opportunities Contacting TTO program managers to
discuss their research interests is also encouraged. A current list of program managers is
available at https://www.darpa.mil/about/offices/tto#pm
DARPA\Multi X Office (MXO): Office-wide Innovative Solutions (Advanced materials, Secure Supply Chains, and Next-generation Resilient Mission Technologies Beyond CMOS)
Proposal due date: By Government invitation stemming from the abstract review on a rolling basis until 4:00 PM on the closing date: June 4, 2027
The three technical thrusts of MXO’s Office-wide Innovative Solutions are:
Thrust 1 – Materials and components to expand the foundation:
Develop next-generation materials and hardware beyond CMOS to create secure, resilient, and scalable foundational technologies that reduce vulnerability and provide long-term military and economic advantage.
Thrust 2 – Tools and processes for indigenous development:
Strengthen domestic manufacturing and supply chains by developing new tools and processes, reducing reliance on foreign sources, and building secure, independent industrial capabilities.
Thrust 3 – New modalities to achieve mission effects:
Enable more resilient sensing, computing, communication, and other mission functions using new technologies, including non-traditional and hybrid approaches beyond conventional electronics.
DARPA\Defense Sciences Office (DSO): Defense Sciences Office (DSO) Office-wide BAA
soliciting proposals which investigate innovative approaches that enable revolutionary advances in science, devices, or systems for national security applications. Specifically excluded is research that primarily results in evolutionary improvements to the existing state of practice.
Technical Thrust Area Descriptions:
- Materials, Manufacturing, and Energy Systems
Breaking the tensions between performance and efficiency for new materials, manufacturing flexibility, propulsion, and energy availability.
- Sensing, Measuring, and Affecting
Pushing the fundamental limits for orders-of-magnitude improvement in awareness, communications, and control.
- Math, Computation, and Processing
Enabling quantum, and reimagining classical, computing for enhanced efficiency and new capabilities.
- Complex, Dynamic, and Intelligent Systems.
Revolutionizing scientific methods for harnessing complex and adaptive systems, from materials to human-AI (artificial intelligence) ecosystems
https://sam.gov/opp/b77f1caefb244d1193ded7f6187ede52/view
US Army Medical Research and Development Command: Broad Agency Announcement (BAA) for Extramural Medical Research
(Pre-proposals/pre-applications may be submitted at any time throughout the 5-year period from the BAA release date to the BAA closing date)
Research Areas of Interest (please see BAA for more details)
- Military Infectious Diseases Research Program
Research and development of solutions for the prevention, treatment, and diagnosis of infectious diseases
- Combat Casualty Care Research Program
- technologies to stop blood loss, resuscitate the casualty, and limit the immediate, short-,and long-term deleterious consequences of severe hemorrhage:
B technologies to diagnose and to limit the immediate, short-, and long-term impairments that follow TBI
- Technologies to diagnose and reduce acute secondary organ damage
- The delivery of care during transport
- Clinical practice of novel/optimized treatments for severe burn injuries
- Pain Management
- Regenerative Medicine
- Autonomous Care and Evacuation / Medical Assist Support Technologies (MAST)
- Medical Countermeasures (MCMs) for Acute Radiation Exposure
- Combined Injury
III. Military Operational Medicine Research Program
- Injury Prevention and Treatment
- Psychological Health and Resilience
- Physiological Health and Performance
- Environmental Health and Protection
- Medical Biological Defense Research Program
- Viral, Toxin, and Bacterial Studies
- Drug Development
- Identification, Diagnosis, and other Medical Interventions
- Biosurveillance(BSV)
- Medical Chemical Defense Research Program
Funding: not specified. Duration: 4 years.
https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=549112
US Department of Health & Human Services/Office of Biomedical Advanced Research and Development Authority (BARDA): Division of Research, Innovation & Ventures (DRIVe)- (Abstracts)
(Abstracts may be submitted at any time until the closing date)
AOI #20 DRIVe Forward
Aims to develop products, capabilities, and technologies to detect threats, improve patient care, including ancillary supplies and resources, as well as novel approaches to develop, clinically validate, and deploy/distribute MCMs rapidly and agnostically.
Especially interested in proposals that aim to address one or more of the following topics:
- Microbiome-based therapies
- Resilience to infection
- Next-generation vaccines
- Next-generation therapeutic antibodies
- Artificial blood products
- Extremely mobile viral diagnostic platforms for use in extremely remote settings
- Non-pharmacological approaches for enhanced immunity
Funding: up to $750K.
https://drive.hhs.gov/partner.html
https://drive.hhs.gov/files/ezbaa_files/DRIVe_EZ-BAA_Special_Instructions_01.pdf
DARPA\ Strategic Technology Office (STO): Strategic Technology Office-wide Innovation Solutions- Abstracts
(Abstract due date: Abstracts may be submitted on a rolling basis until closing date)
Proposed research should investigate innovative approaches that enable revolutionary advances in science, devices, or systems.
Focus areas:
STO looks broadly at disruptive defense technologies across all domains (air, land, sea, space), aiming to develop proof-of-concept mission systems for complex modern warfare environments.
Topics of interest (non-exclusive):
These include AI, autonomy, robotics, advanced computing, communications, sensors, photonics, radar, EW, directed energy, human–machine interaction, logistics, space and undersea technologies, resilient systems, advanced manufacturing, and systems-of-systems, among many others.
Researchers are encouraged to:
- Check existing STO programs to avoid duplication
- Contact DARPA STO program managers to discuss fit and novelty
DOD/ DEVCOM Army Rsearch Laboratory (ARL): Broad Agency Announcement (BAA) Foundational Research (W911NF-23-S-0001)
(Accepting applications on a rolling basis until the deadline)
Research Areas of Interest (please see BAA for more details)
DEVCOM ARL executes intramural and extramural research organized by eleven competencies
that provide the Army with foundational expertise and specialized capabilities grounded in
scientific excellence and driven by unique Army challenges.
The eleven DEVCOM ARL competencies are:
- Biological and Biotechnology Sciences
- Electromagnetic Spectrum Sciences
- Energy Sciences
- Humans in Complex Systems
- Mechanical Sciences
- Military Information Sciences
- Network, Cyber, and Computational Sciences
- Photonics, Electronics, and Quantum Sciences
- Sciences of Extreme Materials
- Terminal Effects
- Weapons Sciences
https://www.grants.gov/search-results-detail/344592
For the full list of opportunities under this BAA:
https://cftste.experience.crmforce.mil/arlext/s/arl-opportunities
Simons Foundation (SFARI): New Ideas (Autism Research) -LOI
Applications are accepted on a rolling basis
The goal of the New Ideas Award is to provide early-stage support for bold, exploratory research that tests novel hypotheses and opens new conceptual or experimental directions in the study of autism and related neurodevelopmental disorders (NDD). Proposed research may draw on any scientific discipline, methodology or experimental system (including humans) and may operate at any scale or level of analysis. All projects should include a compelling case for the relevance and potential of the proposed experiments to SFARI’s mission. Investigators who have not previously been funded by SFARI are especially encouraged to apply.
Funding: up to of $300,000 per year for 2 years.
Lundbeck Foundation: Frontier Grants (Continuous Call)
Frontier Grants facilitate transitions from basic research to attractive prospects for biotech investors
Lundbeck Foundation has now introduced Frontier Grants to support critical activities to advance and consolidate basic research projects, with significant potential, into attractive prospects for investors. The purpose of the grant is to advance mature research projects to become financeable and commercially tangible venture opportunities.
Purpose:
A Frontier Grant (FG) provides financial and interactive support to test and develop the commercial and translational potential of a basic research finding together with the researcher and allowing for mentoring and professional development activity.
Criteria – Who can apply:
Field must be within biomedicine or health sciences, i.e., not limited to brain health.
The research must be affiliated with a Danish non-commercial research institution – international collaboration is allowed.
duration of up to 18 months and a max budget of DKK 5.0 M (with optional 2.5 M and +6 months extension).
https://lundbeckfonden.com/apply-grants/frontier-grants
DOD/ United States Special Operations Command (USSOCOM): Broad Agency Announcement (BAA) Extramural Biomedical and Human Performance Research and Development (HT9425-23-S-SOC1)
(Pre-proposals/pre-applications may be submitted at any time throughout the 5-year period from the BAA release date to the BAA closing date)
Research Areas of Interest (please see BAA for more details)
- Damage Control Resuscitation
- Prolonged Field Care (PFC)
- Portable Lab Assays and Diagnostics
- Force Health Protection and Environmental Medicine
- Brain Health
- Immune Response
- Chronic Pain
- Automation of Systematic Reviews and Metanalysis
- Medical Simulation and Training Technologies
- Human Performance Optimization
- Canine Medicine and Performance
Most projects are anticipated to have a total cost at or below $1,500,000 (including indirect costs). Projects that have a total cost higher than $1,500,000 (including Indirect costs) with outstanding scientific merit that meet a critical need may be accepted; however the total cost of these projects are not to exceed $5,000,000.00 (including Indirect costs).
Duration: up to 5 years.
https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=549113
U.S. Air Force (AFOSR): Research Interests of the Air Force – Engineering, Complex systems, Information and networks, Chemistry, Physical, Biological sciences (FA9550-23-S-0001)
(Open on an ongoing basis until superseded)
AFOSR is looking for new basic research ideas and is open to considering any unique and revolutionary concepts (pre-coordination is strongly encouraged). Funding ranges are $100-300K per year for 3 to 5 years.
ENGINEERING AND COMPLEX SYSTEMS
- Dynamic Materials and Interactions
- GHz-THz Electronics
- Energy, Combustion and Non-Equilibrium Thermodynamics
- Unsteady Aerodynamics and Turbulent Flows
- High-Speed Aerodynamics
- Aerospace Composite Materials
- Multiscale Structural Mechanics and prognosis
- Propulsion and Power
- Agile Science for Test and Evaluation
INFORMATION AND NETWORKS
- Computational Cognition and Machine Intelligence
- Computational Mathematics
- Dynamical Systems and Control Theory
- Dynamic Data and Information Processing
- Information Assurance and Cybersecurity
- Mathematical Optimization
- Science of Information, Computation, Learning, and Fusion
- Trust and Influence
- Complex Networks
- Cognitive and Computational Neuroscience
PHYSICAL SCIENCES
- Aerospace Materials for Extreme Environments
- Atomic and Molecular Physics
- Electromagnetics
- Optoelectronics and Photonics
- High Energy Radiation Matter Systems
- Quantum Information Sciences
- Physics of Sensing
- Space Science
- Ultrashort Pulse Laser-Matter Interactions
- Condensed Matter Physics
- Astrodynamics
CHEMISTRY AND BIOLOGICAL
- Biophysics
- Human Performance and Biosystems
- Mechanics of Multifunctional Materials and Microsystems
- Molecular Dynamics and Theoretical Chemistry
- Natural Materials and Systems
- Organic Materials Chemistry
https://www.grants.gov/search-results-detail/345653
Anytime: Malan Syndrome Foundation
to advance the current understanding of Malan syndrome and identify disease-modifying treatments.
Funding: up to $30,000 for one year, may be renewed for a second year, based on satisfactory progress.
www.malansyndrome.org/research-grant-program
https://drive.google.com/file/d/1m-RReH2f7jUsmYsXtknPSVORepn_ecdr/view
